Shahana Majid
Overview
Explore the profile of Shahana Majid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
3878
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitsui Y, Chang I, Fukuhara S, Hiraki M, Arichi N, Yasumoto H, et al.
BMC Cancer
. 2022 Jul;
22(1):813.
PMID: 35879687
No abstract available.
2.
Kawamoto K, Okino S, Place R, Urakami S, Hirata H, Kikuno N, et al.
Clin Cancer Res
. 2021 May;
27(9):2665.
PMID: 33941548
No abstract available.
3.
Kulkarni P, Dasgupta P, Hashimoto Y, Shiina M, Shahryari V, Tabatabai Z, et al.
Cancer Res
. 2021 Jan;
81(6):1500-1512.
PMID: 33500248
Metastasis is the leading cause of mortality from kidney cancer, and understanding the underlying mechanism of this event will provide better strategies for its management. Here we investigated the biological,...
4.
Kulkarni P, Dasgupta P, Bhat N, Hashimoto Y, Saini S, Shahryari V, et al.
Toxicol Appl Pharmacol
. 2020 Nov;
409:115308.
PMID: 33129824
This study investigated the role of the PI3K/Akt pathway in cadmium (Cd) induced malignant transformation of normal prostate epithelial (PWR1E and RWPE1) cells. Both PWR1E and RWPE1 cells were exposed...
5.
Bhagirath D, Liston M, Patel N, Akoto T, Lui B, Yang T, et al.
Oncogene
. 2020 Oct;
39(49):7209-7223.
PMID: 33037409
Therapy-induced neuroendocrine prostate cancer (NEPC), an extremely aggressive variant of castration-resistant prostate cancer (CRPC), is increasing in incidence with the widespread use of highly potent androgen receptor (AR)-pathway inhibitors (APIs)...
6.
Dasgupta P, Kulkarni P, Majid S, Hashimoto Y, Shiina M, Shahryari V, et al.
Cell Death Dis
. 2020 Aug;
11(8):660.
PMID: 32814766
The molecular heterogeneity of renal cell carcinoma (RCC) complicates the therapeutic interventions for advanced metastatic disease and thus its management remains a significant challenge. This study investigates the role of...
7.
Dasgupta P, Kulkarni P, Bhat N, Majid S, Shiina M, Shahryari V, et al.
Toxicol Appl Pharmacol
. 2020 Jun;
401:115102.
PMID: 32512071
Purpose: Cadmium (Cd) is reported to be associated with carcinogenesis. The molecular mechanisms associated with Cd-induced prostate cancer (PCa) remain elusive. Materials And Methods: RWPE1, PWR1E and DU 145 cells...
8.
Imai-Sumida M, Dasgupta P, Kulkarni P, Shiina M, Hashimoto Y, Shahryari V, et al.
Cell Physiol Biochem
. 2020 Jan;
54(1):53-70.
PMID: 31961100
Background/aims: Genistein, a soy isoflavone, has been shown to have anti-cancer effects in various cancers including renal cancer. Long non-coding RNA, HOX transcript antisense RNA (HOTAIR), is involved in cancer...
9.
Bhagirath D, Dahiya R, Majid S, Tabatabai Z, Saini S
J Vis Exp
. 2019 Dec;
(153).
PMID: 31814621
Ablation of androgen receptor (AR) signaling by androgen deprivation is the goal of the first line of therapy for prostate cancer that initially results in cancer regression. However, in a...
10.
Ursu S, Majid S, Garger C, de Semir D, Bezrookove V, Desprez P, et al.
Oncogenesis
. 2019 Aug;
8(8):42.
PMID: 31409772
Cholangiocarcinoma (CCA) is a rare, highly invasive malignancy, and its incidence is increasing globally. MicroRNAs (miRNAs) mediate a wide array of cellular and biological processes and are dysregulated in various...